Compounds > 2,2-bis(4-glycidyloxyphenyl)propane
Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Kidney Diseases

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Kidney Diseases in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahmoud, MF1
El Shazly, SM1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Kidney Diseases

ArticleYear
Pioglitazone protects against cisplatin induced nephrotoxicity in rats and potentiates its anticancer activity against human renal adenocarcinoma cell lines.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 51

    Topics: Animals; Benzhydryl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cisplatin; Epoxy Compounds;

2013